𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety and efficacy of Myobloc® (botulinum toxin type B) for sialorrhea in Parkinson's disease (PD) patients

✍ Scribed by Pappert Eric; Reinhard Sharon; Salazar-Grueso Edgar

Book ID
116922172
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
39 KB
Volume
51
Category
Article
ISSN
0041-0101

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of botulinum toxin t
Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: A prospective double-blind trial
✍ Robert Chinnapongse; Kristen Gullo; Paul Nemeth; Yuxin Zhang; Lynn Griggs 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 854 KB

## Abstract Sialorrhea (drooling) is a common symptom of Parkinson's disease (PD) that can significantly impair a patient's health and quality of life. Fifty‐four PD subjects with troublesome sialorrhea were enrolled using a multicenter, randomized, double‐blind, sequential‐dose escalation design i

Safety and efficacy of botulinum toxin t
Safety and efficacy of botulinum toxin type B (Myobloc) in adductor spasmodic dysphonia
✍ Charles H. Adler; Stephen F. Bansberg; Kari Krein-Jones; Joseph G. Hentz 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

## Abstract This single‐site, open‐label, dose‐finding study evaluated the safety and efficacy of botulinum toxin type B (BoNT‐B; Myobloc) for the treatment of adductor spasmodic dysphonia (AdSD) in 13 patients. Three patients received a total of 50 U (25 U per vocal fold); the same three subsequen